South & Central America Arterial Blood Gas Kits Market
The South & Central America arterial blood gas kits market was valued at US$ 30,279.71 thousand in 2023 and is expected to reach US$ 51,046.16 thousand by 2031; it is estimated to register a CAGR of 6.7% from 2023 to 2031.
The inability to run rapid diagnoses is a significant cause of deaths resulting from various diseases in emerging countries. An effective diagnostic infrastructure requires stable electrical power, sophisticated instruments, expensive reagents, and highly trained professionals; thus, diagnoses in developing countries are often limited by the unavailability of these resources. Moreover, the existing diagnostic capabilities result in long assay times, rendering them unsuitable for settings with limited resource availability. Point-of-care testing offers immediate diagnostic results at or near the patient's location, enabling rapid clinical decision-making, streamlined workflows, and enhanced patient outcomes. The need for timely interventions, efficient diagnostic processes, and personalized healthcare delivery fuels the demand for decentralized testing solutions. Point-of-care arterial blood gas kits allow healthcare providers to perform critical diagnostic tests at the patient's bedside, in emergency departments, or in remote settings, facilitating on-the-spot assessment of blood gas parameters, electrolyte levels, and acid–base status. The accessibility and immediacy of point-of-care analyzers empower clinicians to promptly initiate appropriate treatments, monitor patient responses in real time, and optimize clinical decision-making in acute care scenarios. The shift toward point-of-care diagnostics also drives technological advancements in arterial blood gas kits as manufacturers focus on developing compact, automated, and easy-to-use devices that deliver accurate and fast results. The seamless integration of point-of-care analyzers into healthcare workflows enhances operational efficiency, reduces turnaround times for results, and improves the overall quality of patient care. Thus, as healthcare settings embrace the advantages of point-of-care testing, the demand for portable and user-friendly arterial blood gas kits is rising in developing countries, which is likely to create growth opportunities for the market in the coming years.
As per the study titled “Prevalence of people at risk of developing type 2 diabetes and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil,” published in 2020, Brazil is one of the top 10 countries across the world in terms of the total number of diabetes cases recorded every year. The International Diabetes Federation (IDF) Diabetes Atlas 2021 estimated that 15.7 million people aged 20–79 years have diabetes in Brazil. The number is expected to reach 23.2 million by 2045. Blood gas and electrolyte analyzers can detect acid–base imbalances that can cause metabolic diseases such as diabetes. According to the data from the Pan American Health Organization (PAHO), Brazil had over 30 million people aged 60 years and above in 2022, representing 13% of the country's population. By 2030, the number of cases is expected to reach ~50 million, representing 24% of the total populace. As per the Brazil Statistical Institute, the country’s population aged 65 and above is expected to hold a 36% share of the total population by 2050. A majority of the geriatric population in the country suffers from asthma and COPD. An upsurge in the geriatric population across the country, coupled with the increasing prevalence of chronic disorders such as kidney conditions, respiratory disorders, and diabetes, is likely to create lucrative opportunities for the arterial blood gas kits market growth during the forecast period.
Strategic insights for the South & Central America Arterial Blood Gas Kits provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 30,279.71 thousand |
| Market Size by 2031 | US$ 51,046.16 thousand |
| Global CAGR (2023 - 2031) | 6.7% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Syringe Type
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
The geographic scope of the South & Central America Arterial Blood Gas Kits refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The South & Central America arterial blood gas kits market is categorized into syringe type, type, usage, application, needle gauge, syringe volume, end user, and country.
Based on syringe type, the South & Central America arterial blood gas kits market is bifurcated into luer slip syringe and luer lock syringe. The luer lock syringe segment held a larger market share in 2023.
In terms of type, the South & Central America arterial blood gas kits market is bifurcated into vented and non-vented. The vented segment held a larger market share in 2023.
By usage, the South & Central America arterial blood gas kits market is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger market share in 2023.
Based on application, the South & Central America arterial blood gas kits market is bifurcated into in vitro diagnostics and electrolyte analysis. The in vitro diagnostics segment held a larger market share in 2023. Furthermore, the in vitro diagnostics segment is sub segmented into pH blood gas, oxygen content, and others.
In terms of needle gauge, the South & Central America arterial blood gas kits market is segmented into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held the largest market share in 2023.
Based on syringe volume, the South & Central America arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3ml segment held the largest market share in 2023.
By end user, the South & Central America arterial blood gas kits market is categorized into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics held the largest market share in 2023.
Based on country, the South & Central America arterial blood gas kits market is segmented into Brazil, Argentina, Colombia, and the Rest of South & Central America. Brazil dominated the South & Central America arterial blood gas kits market share in 2023.
Radiometer Medical ApS, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC (AirLife), SARSTEDT AG & Co KG, and Lepu Medical Technology Beijing Co Ltd. are among the leading companies operating in the South & Central America arterial blood gas kits market.
The South & Central America Arterial Blood Gas Kits Market is valued at US$ 30,279.71 thousand in 2023, it is projected to reach US$ 51,046.16 thousand by 2031.
As per our report South & Central America Arterial Blood Gas Kits Market, the market size is valued at US$ 30,279.71 thousand in 2023, projecting it to reach US$ 51,046.16 thousand by 2031. This translates to a CAGR of approximately 6.7% during the forecast period.
The South & Central America Arterial Blood Gas Kits Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Arterial Blood Gas Kits Market report:
The South & Central America Arterial Blood Gas Kits Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Arterial Blood Gas Kits Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Arterial Blood Gas Kits Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Arterial Blood Gas Kits Market
